Trading Signals: ATRA Stock Price Prediction and Forecast (Mon. Oct. 26, 2015 - Wed. Sep. 14, 2022)(Atara Biotherapeutics, Inc.)
| ATRA latest price $11.3200 (-23.57%) ($11.1600 - $15.7700) on Tue. May. 26, 2020. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 9.39% (three month average) | RSI | 68 | Latest Price | $11.3200(-23.57%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | ATRA advances 0.3% a day on average for past five trading days. | Weekly Trend | ATRA advances 20.1% a week on average for past two weeks. | Market Behavior | Value stock rally for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support ATRA advance at 0% a week (0% probability) XBI(53%) ARKG(45%) IBB(45%) ARKK(43%) IWO(42%) | Factors Impacting ATRA price | ATRA will decline at least -4.695% in a week (0% probabilities). VIXM(-31%) VXX(-27%) UNG(-10%) UUP(-8%) TLT(-7%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -4.695% (StdDev 9.39%) | Hourly BBV | 0 () | Intraday Trend | -27.4% | | | |
|
5 Day Moving Average | $13.28(-14.76%) | 10 Day Moving Average | $11.97(-5.43%) | 20 Day Moving Average | $10.51(7.71%) | To recent high | -24.2% | To recent low | 98.9% | Market Cap | $841m | | | | Atara Biotherapeutics, Inc. operates as a clinical stage company, which engages in the development of novel therapeutics for patients with cancer, autoimmune, and viral diseases. Its pipeline includes Tab-cel, ATA188, ATA2271/ATA3271, and ATA3219. The company was founded by Isaac E. Ciechanover on August 22, 2012 and is headquartered in South San Francisco, CA. |